{"id":661,"date":"2001-12-01T12:04:00","date_gmt":"2001-12-01T11:04:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2001\/die-30-kostenintensivsten-arzneimittel-in-berlin"},"modified":"2022-03-17T14:10:01","modified_gmt":"2022-03-17T13:10:01","slug":"die-30-kostenintensivsten-arzneimittel-in-berlin","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2001\/die-30-kostenintensivsten-arzneimittel-in-berlin","title":{"rendered":"Die 30 kostenintensivsten Arzneimittel in Berlin"},"content":{"rendered":"<p>Im Oktober 2001 hat die Kassen\u00e4rztliche Vereinigung Berlin ihren Mitgliedern in Zusammenarbeit mit der AOK und allen Ersatzkassen eine \u00dcbersicht \u00fcber die \u00e4rztlichen Verordnungen der 30 kostenintensivsten Arzneimittel des 1. Quartals 2001 zugeschickt. Insgesamt wurden f\u00fcr diese Verordnungen mehr als 30 Mio. DM ausgegeben (s. Tab. 1). Beigef\u00fcgt sind einige sehr sachliche Kommentare, wie die [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Im Oktober 2001 hat die Kassen\u00e4rztliche Vereinigung Berlin ihren Mitgliedern in Zusammenarbeit mit der AOK und allen Ersatzkassen eine \u00dcbersicht \u00fcber die \u00e4rztlichen Verordnungen der 30 kostenintensivsten Arzneimittel des 1. Quartals 2001 zugeschickt. Insgesamt wurden f\u00fcr diese Verordnungen mehr als 30 Mio. DM ausgegeben (s. Tab. 1). Beigef\u00fcgt sind einige sehr sachliche Kommentare, wie die [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[1614,130,1611,316,309,312,314,313,315,255,317,320,311,307,319,310,1046,1609,451,73,449,1022,1610,1615,1608,1612,1032,1613,413,455,453,1619,1617,49,459,1618,456,321,257,633,111,157,1616,291,115,114,370,1607,1035,1606,306,505,443,382],"class_list":["post-661","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-abacavir","tag-ace-hemmer","tag-amlodipin","tag-angiotensin-ii-antagonisten","tag-angiotensin-ii-blocker","tag-angiotensin-ii-inhibitoren","tag-angiotensin-ii-rezeptor-antagonisten","tag-angiotensin-ii-rezeptor-blocker","tag-angiotensin-ii-rezeptor-inhibitoren","tag-arzneimittel","tag-at-ii-antagonisten","tag-at-ii-blocker","tag-at-ii-inhibitoren","tag-at-ii-rezeptor-antagonisten","tag-at-ii-rezeptor-blocker","tag-at-ii-rezeptor-inhibitoren","tag-atorvastatin","tag-cerivastatin","tag-cholesterinsynthese-hemmer","tag-clopidogrel","tag-cse-hemmer","tag-efavirenz","tag-epoetin-alfa","tag-erythropoese-stimulierende-wirkstoffe","tag-erythropoietin","tag-esa","tag-esomeprazol","tag-fentanyl","tag-glimepirid","tag-hmg-coa-reduktase-hemmer","tag-hypercholesterinaemie","tag-insulin-glargin","tag-insulin-human-isophan","tag-insulin-lispro","tag-interferon-alfa-2b","tag-lamivudin-zidovudin","tag-lipidsenker","tag-losartan","tag-medikamente","tag-metoprolol","tag-omeprazol","tag-orale-antidiabetika","tag-pamidronsaeure","tag-pantoprazol","tag-protonenpumpen-hemmer","tag-protonenpumpenhemmer","tag-ramipril","tag-ramipril-hydrochlorothiazid","tag-ribavirin","tag-salmeterol-fluticason","tag-sartane","tag-simvastatin","tag-statine","tag-stavudin"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/661","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=661"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/661\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=661"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=661"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=661"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}